Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
Diabetes Care 2023 May 01;46(5)998-1004, T Heise, JH DeVries, S Urva, J Li, EJ Pratt, MK Thomas, KJ Mather, CA Karanikas, J Dunn, A Haupt, Z Milicevic, T CoskunFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.